37 participants
Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-09-19
- Start Date:
- 2024-10-01
- Completion:
- 2026-03-01
Conditions
- Platinum-resistant Ovarian Cancer (PROC)
- Immunotherapy
Interventions
- DRUG
No Results Yet